LENZ
LENZ
US52635N1037
LENZ Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 19.088.000 --
--
Cost of Revenue 418.000 --
--
Gross Profit 18.670.000 --
--
109.808.000 58.610.000
87.4%
Operating Income -91.138.000 -58.610.000
55.5%
Pretax Income -81.625.000 -49.768.000
64.0%
Net Income Common Stockholders -82.127.000 -49.769.000
65.0%
-- --
--
-- --
--
ende